Dynavax Technologies
DVAX
#4936
Rank
S$2.32 B
Marketcap
S$19.77
Share price
0.00%
Change (1 day)
4.33%
Change (1 year)

Earnings for Dynavax Technologies (DVAX)

Earnings in 2025 (TTM): -S$48.58 Million

According to Dynavax Technologies 's latest financial reports the company's current earnings are S$0.33 Billion. In 2024 the company made an earning of S$48.01 Million, an increase over its 2023 earnings that were of S$3.04 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dynavax Technologies from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$48.58 Million-201.17%
2024 S$48.01 M1475.31%
2023 S$3.04 M-99.2%
2022 S$0.38 B238.78%
2021 S$0.11 B-257.89%
2020 -S$71.64 Million-58.58%
2019 -S$0.18 Billion-9.32%
2018 -S$0.2 Billion60.44%
2017 -S$0.12 Billion-15.8%
2016 -S$0.15 Billion4.22%
2015 -S$0.14 Billion16.54%
2014 -S$0.12 Billion37.09%
2013 -S$84.79 Million
2010 -S$60.69 Million214.85%
2009 -S$19.28 Million-37.33%
2008 -S$30.76 Million-66.07%
2007 -S$90.66 Million16.92%
2006 -S$77.54 Million170.36%
2005 -S$28.68 Million33.39%
2004 -S$21.51 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$12.99 B-30,175.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$11.44 B-26,587.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$1.98 B-4,693.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$12.49 B-29,009.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$28.59 B-66,267.97%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$17.99 B-41,731.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$12.61 B-29,301.40%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
S$26.34 M-160.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.74 B-6,450.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel